Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$125.00K$125.00Kderived±0.0% vs Q4 2020 Net Income-$4.22M-$4.22MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$5,490,868N/M Operating Cash Flowderived-$5,088,092N/M Free Cash Flowderived-$5,113,734N/M Margins · derivedOperating margin-4392.7%−557.6 pt vs Q4 2020
Net margin-3377.0%−967.3 pt vs Q4 2020
ended Dec 31, 2021 · filed Mar 31, 2022 · 90 d after period end